The unexpected failures of anti-IL-17A in Crohn's disease and of anti-IL-23 in AS are stark reminders of our limited understanding of the pathogenic mechanisms of these diseases and are a call to action to all of us in the biomedical research community. Here, IL23A is linked to Crohn disease.